March 13, 2017
March 13, 2017 —
Each year, at precisely the same moment — 12 p.m. on the East coast, 9 a.m. on the West — thousands of graduating medical school students across the country simultaneously tear open an envelope. The single sheet of paper inside informs each graduate where he or she will do their residencies — in other words, where each will spend the first several years of their careers as working doctors.
March 8, 2017
March 8, 2017 —
Patients with drug-refractory epilepsy have a new treatment option at UC San Diego Health. Instead of traditional surgery, patients may be eligible for a novel technique that allows surgeons to target the abnormal area of brain with laser technology. The MRI-guided laser ablation treatment is a new first-line therapy for patients diagnosed with epilepsy.
March 3, 2017
March 3, 2017 —
UC San Diego Research Affairs –The Office of Innovation and Commercialization launches the first of an eighteen-month entrepreneurial seminar series, free and open to anyone at UC San Diego and the general public, including members of any other research institutions, Mar. 9.
February 27, 2017
February 27, 2017 —
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego are running a Diabetes Intensive Medical Management (DIMM) “tune up” clinic for complex type 2 diabetes patients. In a study published in the March 2017 issue of the Journal of Managed Care & Specialty Pharmacy, the researchers report the clinic’s economic benefits, which include an estimated cost avoidance of $5,287 per DIMM clinic patient over three years.
February 22, 2017
February 22, 2017 —
University of California San Diego School of Medicine researchers screened 10,000 colonies of bacteria found on the epidermis to determine how many had antimicrobial properties and at what rate these are found on healthy and non-healthy skin. In a paper published in Science Translation Medicine, the team reports isolating and growing good bacteria that produce antimicrobial peptides and successfully transplanting it to treat patients with the most common type of eczema, known as atopic dermatitis.
February 21, 2017
February 21, 2017 —
A paradigm-changing study in the journal Nature by cancer researchers and computer scientists at UC San Diego and other institutions found that short fragments of circular DNA that encode cancer genes are far more common in cancer cells than previously believed.
February 17, 2017
February 17, 2017 —
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
February 16, 2017
February 16, 2017 —
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge that is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes complicated skin and skin structure infections. In a randomized, controlled clinical trial — the first of its kind — a multi-institution research team reports that daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children.
February 15, 2017
February 15, 2017 —
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.
February 14, 2017
February 14, 2017 —
Sandra Horning, MD, Chief Medical Officer and executive vice president of global development for Roche and Genentech, a member of the Roche Group, has been named the 2017 recipient of the Duane Roth Memorial Award, which will be presented February 16 at the annual Industry/Academia Translational Oncology Symposium at UC San Diego Moores Cancer Center.
